Antitrust Antitrust

Calcium gluconate probe identified in China's antitrust sweep of pharmaceutical-ingredients sector

By MLex Staff
  • 17 Jan 2020 01:35
  • 17 Jan 2020 01:35
The active pharmaceutical ingredient, or API, calcium gluconate has been newly identified as a target in China's nationwide antitrust sweep of the pharmaceuticals sector.

As MLex has reported, the API industry has been an enforcement priority of China's competition authorities (see here). 

The State Administration for Market Regulation, or

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News